Marson, Anthony ORCID: 0000-0002-6861-8806, Burnside, Girvan
ORCID: 0000-0001-7398-1346, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin, Plumpton, Catrin, Hughes, Dyfrig A
ORCID: 0000-0001-8247-7459, Williamson, Paula
ORCID: 0000-0001-9802-6636 et al (show 10 more authors)
(2021)
The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
LANCET, 397 (10282).
1363 - 1374.
Item Type: | Article |
---|---|
Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Population Health Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
Depositing User: | Symplectic Admin |
Date Deposited: | 17 May 2021 08:59 |
Last Modified: | 07 Jul 2022 11:47 |
Open Access URL: | https://www.thelancet.com/journals/lancet/article/... |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3123017 |